HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Molton Brown Revamped Color Key To Doubling U.S. Sales

This article was originally published in The Rose Sheet

Executive Summary

Molton Brown will replace its existing 110-SKU color collection with 120 redesigned and repackaged SKUs in the third quarter. The color overhaul is part of an aggressive plan to double U.S. sales over the next few years, the London firm said.

You may also be interested in...



British Retailers Czech & Speake, Space.NK Develop U.S. Presence

A premiere U.S. Czech & Speake boutique, slated to open in New York City's SoHo district within the next 12 months, will help the London retailer establish a foothold for stateside expansion, the firm said.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009041

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel